Po-Chung Cheng

ORCID: 0000-0001-9655-2034
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • Diabetes Treatment and Management
  • Lipoproteins and Cardiovascular Health
  • Diabetes Management and Education
  • Cancer Genomics and Diagnostics
  • Diabetes Management and Research
  • Liver Disease Diagnosis and Treatment
  • Antiplatelet Therapy and Cardiovascular Diseases
  • Lung Cancer Treatments and Mutations
  • Parvovirus B19 Infection Studies
  • Diet and metabolism studies
  • Autoimmune and Inflammatory Disorders Research
  • Genetic factors in colorectal cancer
  • Diabetes and associated disorders
  • Cardiovascular Function and Risk Factors
  • Pancreatitis Pathology and Treatment
  • Immune Cell Function and Interaction
  • Peptidase Inhibition and Analysis

Changhua Christian Hospital
2016-2022

China Medical University
2021

Taichung Veterans General Hospital
2015

National Yang Ming University Hospital
2014

National Yang Ming Chiao Tung University
2014

Objective. This study examined the association between serum albumin concentration and ketosis risk in hospitalized individuals with type 2 diabetes mellitus (T2DM). Methods . A retrospective cross-sectional was conducted at a medical center Taiwan. Inclusion criteria were endocrinology ward inpatients exceeding 21 years of age, preexisting diagnosis T2DM, blood glucose above 13.9 millimoles per liter (mmol/L) admission. Individuals without measurement albumin, urine ketone, or hemoglobin...

10.1155/2016/1269706 article EN cc-by Journal of Diabetes Research 2016-01-01

Lung cancer is a leading cause of deaths in the world. Cigarette smoking remains prominent risk factor, but lung incidence has been increasing never smokers. Genetic abnormalities including epidermal growth factor receptor (EGFR) mutations predominate patients. Furthermore, familial aggregations patients with these reflect heritable susceptibility to cancer. The correlation between history and EGFR smokers requires investigation.This was retrospective case-control study that evaluated...

10.3978/j.issn.2072-1439.2015.02.03 article EN PubMed 2015-03-01

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder involving progressive pancreatic dysfunction. A substantial proportion of patients with T2DM cannot achieve euglycemia despite pharmacologic therapy. Preceding clinical studies have shown that hypertension contributes to glucose dysregulation, and investigators in this study hypothesized antihypertensive treatment may improve glycemic control T2DM.This prospective cohort investigates the effect adding drug Amlodipine standard...

10.3389/fendo.2022.935561 article EN cc-by Frontiers in Endocrinology 2022-09-09

Coronary heart disease (CHD) is a prevalent complication of type 2 diabetes mellitus (T2DM). The atherogenic low-density lipoprotein (LDL) cholesterol an established risk factor cardiovascular disease, and evidence also suggests that postprandial plasma glucose (PPG) levels closely delineate CHD mortality in diabetes. investigators hypothesized excursion (PPGE), defined as the difference between 2-hour PPG fasting (FPG), may be associated with LDL patients T2DM. This study enrolled diabetic...

10.1371/journal.pone.0258771 article EN cc-by PLoS ONE 2021-10-20

Coronary heart disease (CHD) is a prevalent complication of type 2 diabetes mellitus (T2DM). The proatherogenic low-density lipoprotein (LDL) cholesterol an established risk factor cardiovascular disease, and evidence also suggests that postprandial plasma glucose (PPG) levels closely delineate CHD mortality in diabetes. investigators hypothesized the addition telehealth consultation to standard antidiabetic therapy may help reduce variability LDL patients with T2DM.This cross-sectional...

10.1530/ec-21-0209 article EN cc-by-nc-nd Endocrine Connections 2021-06-01

Background Heart failure is a frequent complication of type 2 diabetes mellitus (T2DM). Plasma cholesterol, particularly the proatherogenic low-density lipoprotein (LDL) impairs heart function by promoting atheroma formation and ventricular dysfunction. Considering established effect cholesterol on cardiovascular system, we hypothesized that plasma LDL may influence left in individuals with T2DM. Methods This cross-sectional study was conducted at tertiary care hospital Taiwan. Enrollment...

10.3389/fendo.2019.00234 article EN cc-by Frontiers in Endocrinology 2019-04-11

Diabetic kidney disease (DKD) leads to substantial morbidity in patients with type 2 diabetes mellitus (T2DM). Evidence suggests that antidiabetic drug dipeptidyl-peptidase 4 (DPP-4) inhibitors may be able attenuate albuminuria, whereas the influence of sulfonylureas on albuminuria remains unclear. This prospective open-label study investigated effect DPP-4 and urinary albumin excretion, which is a marker renal microvascular abnormality. A total 101 participants newly diagnosed T2DM were...

10.3390/jcm8101715 article EN cc-by Journal of Clinical Medicine 2019-10-17

Hemophagocytic lymphohistiocytosis (HLH) is a syndrome of immune overstimulation. HLH commonly manifests as multiple organ failure without apparent physiological stress. Primary relates to genetic defects, whereas secondary triggered by infection, malignancy, or autoimmune disease. An aberrant natural killer cell absence T lymphocyte apoptosis causes uncontrolled inflammation. Secondary in patients with systemic lupus erythematosus (SLE) uncommon an estimated prevalence 0.9%. This report...

10.11648/j.ajim.20140203.13 article EN American Journal of Internal Medicine 2014-01-01
Coming Soon ...